124 related articles for article (PubMed ID: 19200828)
21. Cytokine profile after rubella vaccine inoculation: evidence of the immunosuppressive effect of vaccination.
Pukhalsky AL; Shmarina GV; Bliacher MS; Fedorova IM; Toptygina AP; Fisenko JJ; Alioshkin VA
Mediators Inflamm; 2003 Aug; 12(4):203-7. PubMed ID: 14514470
[TBL] [Abstract][Full Text] [Related]
22. Associations between race, sex and immune response variations to rubella vaccination in two independent cohorts.
Haralambieva IH; Salk HM; Lambert ND; Ovsyannikova IG; Kennedy RB; Warner ND; Pankratz VS; Poland GA
Vaccine; 2014 Apr; 32(17):1946-53. PubMed ID: 24530932
[TBL] [Abstract][Full Text] [Related]
23. Lymphocyte activation as cytokine gene expression and secretion is related to the porcine reproductive and respiratory syndrome virus (PRRSV) isolate after in vitro homologous and heterologous recall of peripheral blood mononuclear cells (PBMC) from pigs vaccinated and exposed to natural infection.
Ferrari L; Martelli P; Saleri R; De Angelis E; Cavalli V; Bresaola M; Benetti M; Borghetti P
Vet Immunol Immunopathol; 2013 Feb; 151(3-4):193-206. PubMed ID: 23228653
[TBL] [Abstract][Full Text] [Related]
24. HLA genotypes and rubella vaccine immune response: additional evidence.
Ovsyannikova IG; Pankratz VS; Larrabee BR; Jacobson RM; Poland GA
Vaccine; 2014 Jul; 32(33):4206-13. PubMed ID: 24837503
[TBL] [Abstract][Full Text] [Related]
25. Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination.
Ovsyannikova IG; Jacobson RM; Vierkant RA; Jacobsen SJ; Pankratz VS; Poland GA
J Infect Dis; 2005 Feb; 191(4):515-9. PubMed ID: 15655774
[TBL] [Abstract][Full Text] [Related]
26. Possible associations between HLA antigens and the immune responsiveness to attenuated rubella vaccine.
Kato S; Kimura M; Takakura I; Sakakibara T; Inouye H; Tsuji K
Tissue Antigens; 1978 May; 11(5):475-8. PubMed ID: 99841
[TBL] [Abstract][Full Text] [Related]
27. Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population.
Dhiman N; Ovsyannikova IG; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
Tissue Antigens; 2008 Sep; 72(3):211-20. PubMed ID: 18715339
[TBL] [Abstract][Full Text] [Related]
28. Immunogenetics of atopic asthma: association of DRB1*1101 DQA1*0501 DQB1*0301 haplotype with Dermatophagoides spp.-sensitive asthma in a sample of the Venezuelan population.
Lara-Marquez ML; Yunis JJ; Layrisse Z; Ortega F; Carvallo-Gil E; Montagnani S; Makhatadze NJ; Pocino M; Granja C; Yunis E
Clin Exp Allergy; 1999 Jan; 29(1):60-71. PubMed ID: 10051703
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of live trivalent vaccine of measles AIK-C strain, mumps Hoshino strain and rubella Takahashi strain, by virus-specific interferon-gamma production and antibody response.
Nakayama T; Urano T; Osano M; Nakagawa M; Maehara N; Sasaki K; Yamamura AM; Makino S
Microbiol Immunol; 1990; 34(6):497-508. PubMed ID: 2120551
[TBL] [Abstract][Full Text] [Related]
30. Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei.
Ulett GC; Ketheesan N; Hirst RG
Infect Immun; 2000 Apr; 68(4):2034-42. PubMed ID: 10722599
[TBL] [Abstract][Full Text] [Related]
31. Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children.
Dhiman N; Ovsyannikova IG; Jacobson RM; Vierkant RA; Pankratz VS; Jacobsen SJ; Poland GA
Clin Immunol; 2005 May; 115(2):154-61. PubMed ID: 15885638
[TBL] [Abstract][Full Text] [Related]
32. Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine.
Ovsyannikova IG; Dhiman N; Jacobson RM; Vierkant RA; Poland GA
Clin Diagn Lab Immunol; 2003 May; 10(3):411-6. PubMed ID: 12738640
[TBL] [Abstract][Full Text] [Related]
33. HLA and the rubella-specific immune response following vaccination.
Van Eden W; UytdeHaag F; Loggen HG; Plantinga AD; De Vries RR; Van Rood JJ
Exp Clin Immunogenet; 1984; 1(2):70-4. PubMed ID: 6400993
[TBL] [Abstract][Full Text] [Related]
34. Molecular analysis of HLA allelic frequencies and haplotypes in Jordanians and comparison with other related populations.
Sánchez-Velasco P; Karadsheh NS; García-Martín A; Ruíz de Alegría C; Leyva-Cobián F
Hum Immunol; 2001 Sep; 62(9):901-9. PubMed ID: 11543892
[TBL] [Abstract][Full Text] [Related]
35. Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers.
Terada K; Itoh Y; Wakabayashi T; Teranishi H; Akaike H; Ogita S; Ouchi K
Vaccine; 2015 Nov; 33(45):6093-8. PubMed ID: 26275479
[TBL] [Abstract][Full Text] [Related]
36. Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes.
Dhiman N; Ovsyannikova IG; Cunningham JM; Vierkant RA; Kennedy RB; Pankratz VS; Poland GA; Jacobson RM
J Infect Dis; 2007 Jan; 195(1):21-9. PubMed ID: 17152005
[TBL] [Abstract][Full Text] [Related]
37. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. II. Influence of the HLA B8, DR3, DQ2 haplotype.
Godot V; Harraga S; Beurton I; Tiberghien P; Sarciron E; Gottstein B; Vuitton DA
Clin Exp Immunol; 2000 Sep; 121(3):491-8. PubMed ID: 10971516
[TBL] [Abstract][Full Text] [Related]
38. Human leukocyte antigen class I and class II allele frequencies and HIV-1 infection associations in a Chinese cohort.
Li S; Jiao H; Yu X; Strong AJ; Shao Y; Sun Y; Altfeld M; Lu Y
J Acquir Immune Defic Syndr; 2007 Feb; 44(2):121-31. PubMed ID: 17106278
[TBL] [Abstract][Full Text] [Related]
39. HLA class I supertypes in type 1 diabetic children in an urban children's hospital.
Antal Z; Jarchum I; DiLorenzo TP
Ann N Y Acad Sci; 2008 Dec; 1150():86-9. PubMed ID: 19120273
[TBL] [Abstract][Full Text] [Related]
40. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines.
Ausiello CM; Urbani F; la Sala A; Lande R; Cassone A
Infect Immun; 1997 Jun; 65(6):2168-74. PubMed ID: 9169747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
